Twenty percent of teens, young adults seeking treatment for substance use disorder had elevated Social Responsiveness Scale-2 Total T-scores
For patients with opioid use disorder taking buprenorphine-naloxone, it is deemed appropriate to continue three times-daily dosing
There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
Improvement seen in treatment satisfaction and several secondary end points for depot buprenorphine versus sublingual buprenorphine
Differences between the two trajectories persist in opioid fills, misuse beyond 12 months
Concurrent tobacco use and minority race/ethnicity status further worsen outcomes with cannabis use disorder during pregnancy